Quick Takeaways
- Lind Global Fund II LP filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 6.6%.
- Date of event: 31 Dec 2025.
Lind Global Fund II LP - 31 Dec 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX)
- Filing Manager
- Lind Global Fund II LP
- Reporting Manager
- Lind Global Fund II LP
- Symbol
- TENX
- Shares outstanding
- 6,683,988 shares
- Disclosed Ownership
- 442,480 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:08:22 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Lind Global Fund II LP disclosed 6.6% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lind Global Fund II LP | 6.6% | 442,480 | 442,480 | 0 | By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Lind Global Partners II LLC | 6.6% | 442,480 | 442,480 | 0 | /s/ Jeff Easton | Jeff Easton, Managing Member | |
| EASTON JEFF | 6.6% | 442,480 | 442,480 | 0 | /s/ Jeff Easton | Jeff Easton |